Influence of X-Chromosome Inactivation in Pathogenesis of Turner Syndrome
Epigenomes · 02.07.2026 · 10 (3) · 43
DOI: 10.3390/epigenomes10030043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epigenomes, online erschienen am 02.07.2026. Verfasst von Ana-Maria Grigore und 6 weiteren Autor:innen. Beteiligte Einrichtung: Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Die Arbeit nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grigore T. Popa University of Medicine and Pharmacy.
Abstract (Originalsprache)
Turner syndrome (TS), a disorder caused by the complete or partial absence of an X chromosome, exhibits significant clinical variability that cannot be fully explained by chromosomal anomalies alone. This narrative review highlights the crucial role of epigenetic mechanisms, particularly X-chromosome inactivation (XCI), in shaping the TS phenotype. The haploinsufficiency of genes that normally escape XCI is a primary driver of TS features. The specific epigenetic consequences depend on the chromosomal anomaly. In complete monosomy (45,X), the absence of escape-mediated dosage compensation genes from a second X chromosome amplifies haploinsufficiency across X-linked escape genes. Isochromosome Xq (i(Xq)) variants involve the loss of the short arm (Xp) and duplication of the long arm (Xq), creating a dual dosage imbalance with extreme XCI skewing. Carriers of i(Xq) also have a heightened risk for autoimmune disorders compared to those with 45,X TS. For ring-X chromosomes (r(X)), which are mitotically unstable, the functional status of the XIST gene is critical. If the ring is XIST-negative, it remains transcriptionally active, resulting in functional disomy and a more severe phenotype with pronounced neurodevelopmental and craniofacial features. Ultimately, the clinical heterogeneity in TS arises from a complex interplay of the specific chromosomal structure, tissue-specific mosaicism, XIST function, and variable escape from XCI, defining TS as a disorder of epigenetic and gene-regulatory imbalance. However, future research requires a better understanding of the complex mechanism of X-chromosome inactivation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Mother and Child Medicine Department, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Medical III Department, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
ORCID-Profile: Vlad Teodor Iacob, Lucian-Mihai Antoci, Monica Cristina Pânzaru, Lăcrămioara Ionela Butnariu
Förderung
- Grigore T. Popa University of Medicine and Pharmacy
Zitieren
APA
Grigore, A. M., Caba, L., Iacob, V. T., Antoci, L. M., Pânzaru, M. C., Butnariu, L. I., & Gorduza, E. V. (2026). Influence of X-Chromosome Inactivation in Pathogenesis of Turner Syndrome. Epigenomes, 10(3), 43. https://doi.org/10.3390/epigenomes10030043
Vancouver
Grigore AM, Caba L, Iacob VT, Antoci LM, Pânzaru MC, Butnariu LI, et al. Influence of X-Chromosome Inactivation in Pathogenesis of Turner Syndrome. Epigenomes. 2026;10(3):43. doi:10.3390/epigenomes10030043
BibTeX
@article{Grigore2026,
author = {Grigore, Ana-Maria and Caba, Lavinia and Iacob, Vlad Teodor and Antoci, Lucian-Mihai and Pânzaru, Monica Cristina and Butnariu, Lăcrămioara Ionela and Gorduza, Eusebiu Vlad},
title = {Influence of X-Chromosome Inactivation in Pathogenesis of Turner Syndrome},
journal = {Epigenomes},
year = {2026},
volume = {10},
number = {3},
pages = {43},
doi = {10.3390/epigenomes10030043}
}
EUVIMED